Last reviewed · How we verify
NCT06696469: cros-sectional
Feasibility and Reliability of Using BeCureTM Virtual Reality in Patients With Stroke
trial testing Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients in Stroke Patients in 34 participants. Currently enrolling.
22 June 2026
Quick facts
| Lead sponsor | Ankara University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 34 |
| Start date | 22 June 2024 |
| Primary completion | 22 June 2026 |
| Estimated completion | 22 June 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients
Conditions studied
- Stroke Patients — all drugs for Stroke Patients →
Sponsor
Ankara University
Who can join
Adults 18 to 80, any sex, with Stroke Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to demonstrate the feasibility and reliability of using virtual reality-based BeCureTM in the assessment of upper extremity motor functions in stroke patients.It is necessary to define the appropriate patient profile for the evaluation of upper extremity motor functions in stroke patients with virtual reality method. We aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications. Therefore, BeCure TM virtual reality system can be feasibly used in the evaluation and rehabilitation of stroke patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06696469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke Patients
Currently open trials in the same condition.
- NCT06765642 — The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients. · NA · recruiting
- NCT06673771 — Effects of Vestibular Rehabilitation on Balance and Post Stroke Fatigue : · NA · recruiting
- NCT06945211 — Task Oriented Mirror Therapy for Upper Limb Motor Function in Stroke Patient · NA · recruiting
- NCT06878677 — Individualized Exercise Prescription With a Data-driven Approach in Individuals With Stroke · NA · recruiting
- NCT06258538 — Effects of Circuit Training Combining Different Types of Distal Robot-assisted and Task-oriented Therapy on Motor Contro · NA · recruiting
Other Ankara University trials
Trials by the same sponsor.
- NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
- NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
- NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
- NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
- NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06696469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara University
- Last refreshed: 22 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06696469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing